A comprehensive view of biontech se. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Biontech reports Q2 net profits down at €1.7B from €2.8B a year ago, with revenue dropping to €3.2B from €5.3B a year ago; results driven by drop in revenue from COVID-19 vaccine as pandemic remains ‘dynamic’

FDA approves emergency use authorization for Moderna and Pfizer-BioNTech COVID-19 vaccines for children as young as six months old; Moderna vaccine administered in two doses, Pfizer vaccine administered in three doses

Pfizer and Biontech complete EU submission for approval of their Omicron-adapted bivalent COVID-19 vaccine; vaccine to be used to treat patents 12 years of age or older if approved

FDA grants full approval of Pfizer and Biontech’s Comirnaty COVID-19 vaccination for kids between 12-years, 15-years old; 9 million kids in US have received primary doses under emergency use authorization, with drug generating Q1 sales of US$13.2B

Curevac sues Biontech for intellectual property rights infringement regarding development of Comirnaty COVID-19 vaccination developed by Biontech and Pfizer; Curevac alleges its work contributed to vaccine development

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count